A Comparison study of Ranibizumab and Aflibercept in patients with naive diabetic macular edema in presence of serous retinal detachment.
CONCLUSIONS: Aflibercept may treate SRD more efficiently in patients with DME compared to Ranibizumab with fewer injections.
PMID: 30983426 [PubMed - as supplied by publisher]
Source: Current Eye Research - Category: Opthalmology Authors: Kaldırım H, Yazgan S, Kırgız A, Atalay K, Savur F Tags: Curr Eye Res Source Type: research
More News: Diabetes | Endocrinology | Eyes | Lucentis | Opthalmology | Ranibizumab Injection | Study | Vitamin A